Indication
Hexavalent Vaccine
1 clinical trial
1 product
Clinical trial
A Phase 4, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of Vaxelis™ in Healthy Children Previously Vaccinated With a 2-Dose Primary Infant Series of Either Vaxelis™ or Hexyon™Status: Completed, Estimated PCD: 2022-08-30
Product
Vaxelis™